Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Atypon full text link Atypon Free PMC article
Full text links

Actions

Share

.2000 Jul;7(4):706-9.
doi: 10.1128/CDLI.7.4.706-709.2000.

Serological detection of infection with diverse human and simian immunodeficiency viruses using consensus env peptides

Affiliations

Serological detection of infection with diverse human and simian immunodeficiency viruses using consensus env peptides

S Masciotra et al. Clin Diagn Lab Immunol.2000 Jul.

Abstract

Cross-species transmission has been shown to play an important role in the emergence of human retroviruses. We developed a generic enzyme immunoassay using synthetic peptides from gp41 and C2V3 consensus sequences (human immunodeficiency virus [HIV] type 1 [HIV-1] groups M, O, and N and the homologous region of simian immunodeficiency virus [SIV] strains from chimpanzees [SIVcpz], SIVcpzGAB1 and SIVcpzANT) to detect divergent HIV and SIV. A cocktail of peptides from gp41 and C2V3 (M-O) detected all HIV-1 group M and O sera and showed cross-reactivity with SIVcpz sera. Further, a mixture of C2V3 peptides (GAB1-ANT) failed to detect HIV-1 infections but reacted with all SIVcpz sera, allowing discrimination of SIVcpz from HIV-1 infections. Since most SIVcpz sera cross-reacted with HIV-1 peptides, we next evaluated SIVcpz serum reactivity with rapid tests for HIV-1/2. SIVcpzANT and SIVcpzUS sera reacted with the Sero-strip and Multispot assays. Both tests are sensitive in detecting group M (97 100%, respectively), although Multispot has lower sensitivity for group O detection (67%) than does Sero-strip (100%). The limited volume and time required to perform these assays make them a generic tool for field screening. The env peptide-based assay and rapid tests should allow for the identification of emerging variants of HIV and SIV.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Burgess-Cassler A, Barriga Angulo G, Wade S, Castillo Torres P, Schramm W A. A field test for the detection of antibodies to human immunodeficiency virus types 1 and 2 in serum or plasma. Clin Diagn Lab Immunol. 1996;3:480–482. - PMC - PubMed
    1. Constantine N T, Zekeng L, Sangare A K, Gurtler L, Saville R I, Anhary H, Wild C. Diagnostic challenges for rapid human immunodeficiency virus assays: performance using HIV-1 group O, HIV-1 group M, and HIV-2 samples. J Hum Virol. 1997;1:45–51. - PubMed
    1. Dorn J, Masciotra S, Yang C, Downing R, Biryawaho B, Mastro T M, Nkengasong J, Pieniazek D, Rayfield M A, Hu D J, Lal R B. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection. J Clin Microbiol. 2000;38:773–780. - PMC - PubMed
    1. Gao F, Bailes E, Robertson D L, Chen Y, Rodenburg C M, Michael S F, Cummins L B, Arthur L O, Peeters M, Shaw G M, Sharp P M, Hahn B H. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 1999;397:436–441. - PubMed
    1. Hu D, Dondero T J, Mastro T D, Gayle H D. Global and molecular epidemiology of HIV. In: Wonnser G P, editor. AIDS and other manifestations of HIV infection. Philadelphia, Pa: Lipponcott-Raven Publishers; 1998. pp. 27–40.

MeSH terms

Substances

LinkOut - more resources

Full text links
Atypon full text link Atypon Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp